Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Real-World Effectiveness of Pentavalent Rotavirus Vaccine Among Bedouin and Jewish Children in Southern Israel.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 1 May 2016

Leshem Eyal, Givon-Lavi Noga, Tate Jacqueline E, Greenberg David, Parashar Umesh D, Dagan Ron

Abstract excerpt

BACKGROUND: Pentavalent rotavirus vaccine (RV5) was introduced into the Israeli National Immunization Program in January 2011. We determined RV5 vaccine effectiveness (VE) in southern Israel, a region characterized by 2 distinct populations: Bedouins living in a low- to middle-income, semirural setting, and Jews living in a high-income, urban setting. METHODS: We enrolled vaccine-eligible children who visited the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arabs
Share to Emergency Service, Hospital

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hospitalization

Share to Immunization Programs

Share to Immunogenicity, Vaccine

Share to Israel

Share to Rotavirus Vaccines

Share to Vaccines, Attenuated

Source

Identifiers

PMID: 27059350
DOI: 10.1093/cid/civ1012

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Real-World Effectiveness of Pentavalent Rotavirus Vaccine Among Bedouin and Jewish Children in Southern Israel.PMID 27059350Read ↗

Incidence, characteristics, and economic burden of rotavirus gastroenteritis associated with hospitalization of israeli children <5 years of age, 2007-2008.Semantic proximity Read ↗

Effectiveness of Monovalent Rotavirus Vaccine Among Young Children in Pakistan: a Test-Negative Case-Control EvaluationSemantic proximity Read ↗

Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011.Semantic proximity Read ↗

Incidence of rotavirus gastroenteritis hospitalizations and genotypes, before and five years after introducing universal immunization in Israel.Semantic proximity Read ↗

Long-term Consistency in Rotavirus Vaccine Protection: RV5 and RV1 Vaccine Effectiveness in US Children, 2012-2013.Semantic proximity Read ↗

Effectiveness of monovalent and pentavalent rotavirus vaccines in Japanese children.Semantic proximity Read ↗

Effectiveness of monovalent rotavirus vaccine in a high-income, predominant-use setting.Semantic proximity Read ↗

Effectiveness of the monovalent G1P[8] human rotavirus vaccine against hospitalization for severe G2P[4] rotavirus gastroenteritis in Belém, Brazil.Semantic proximity Read ↗

Sustained Effectiveness of Rotavirus Vaccine Against Very Severe Rotavirus Disease Through the Second Year of Life, Bolivia 2013-2014.Semantic proximity Read ↗

Impact and effectiveness of pentavalent rotavirus vaccine in children <5 years of age in Burkina Faso.Semantic proximity Read ↗

Impact of rotavirus vaccines on rotavirus disease.Semantic proximity Read ↗

Rotavirus vaccine effectiveness and case-control study on risk factors for breakthrough infections in Germany, 2010-2011.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.